Comparing unknown compounds in a patient’s blood, urine or other biological sample to those in the Global Natural Product ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical ...

Natural Gas Services (NGS) is a top buy with strong profit growth, new dividends, and sector support. Read here for ...

Explore trends before investing – request a sample report today! The Non-NGS Predictive Cancer Diagnostics Market is ...

In its latest quarter, it generated 60% of its revenue from its smallest 3nm and 5nm nodes. In terms of platforms, it ...

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...

Nutritional Growth Solutions Ltd. ( ($AU:NGS) ) has shared an update. Nutritional Growth Solutions Ltd. has secured an interim loan facility from ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...